Goodrx Holdings Stock Alpha and Beta Analysis

GDRX Stock  USD 4.42  0.05  1.12%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Goodrx Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Goodrx Holdings over a specified time horizon. Remember, high Goodrx Holdings' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Goodrx Holdings' market risk premium analysis include:
Beta
1.17
Alpha
0.0572
Risk
2.91
Sharpe Ratio
(0.01)
Expected Return
(0.02)
Please note that although Goodrx Holdings alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Goodrx Holdings did 0.06  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Goodrx Holdings stock's relative risk over its benchmark. Goodrx Holdings has a beta of 1.17  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Goodrx Holdings will likely underperform. At this time, Goodrx Holdings' Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 0.71 in 2025, whereas Enterprise Value Over EBITDA is likely to drop 8.65 in 2025.

Enterprise Value

1.53 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Goodrx Holdings Backtesting, Goodrx Holdings Valuation, Goodrx Holdings Correlation, Goodrx Holdings Hype Analysis, Goodrx Holdings Volatility, Goodrx Holdings History and analyze Goodrx Holdings Performance.
For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.

Goodrx Holdings Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Goodrx Holdings market risk premium is the additional return an investor will receive from holding Goodrx Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Goodrx Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Goodrx Holdings' performance over market.
α0.06   β1.17

Goodrx Holdings expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Goodrx Holdings' Buy-and-hold return. Our buy-and-hold chart shows how Goodrx Holdings performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Goodrx Holdings Market Price Analysis

Market price analysis indicators help investors to evaluate how Goodrx Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Goodrx Holdings shares will generate the highest return on investment. By understating and applying Goodrx Holdings stock market price indicators, traders can identify Goodrx Holdings position entry and exit signals to maximize returns.

Goodrx Holdings Return and Market Media

The median price of Goodrx Holdings for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 4.71 with a coefficient of variation of 4.76. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 4.71, and mean deviation of 0.19. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 23150 shares by Kennedy Kelly J. of Goodrx Holdings subject to Rule 16b-3
12/20/2024
2
Acquisition by Bruehlman Ronald E of 10653 shares of Goodrx Holdings subject to Rule 16b-3
12/31/2024
3
Disposition of 89292 shares by Karsten Voermann of Goodrx Holdings subject to Rule 16b-3
01/08/2025
4
Disposition of 2606 shares by Romin Nabiey of Goodrx Holdings subject to Rule 16b-3
01/15/2025
5
Acquisition by Scott Wagner of 94182 shares of Goodrx Holdings subject to Rule 16b-3
01/21/2025
6
Insider Trading
02/04/2025
7
Disposition of 5202 shares by Romin Nabiey of Goodrx Holdings at 4.84 subject to Rule 16b-3
02/07/2025
8
GoodRx Holdings, Inc. Given Consensus Recommendation of Moderate Buy by Analysts - MarketBeat
02/12/2025
9
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
02/18/2025
10
Insights Into GoodRx Q4 Wall Street Projections for Key Metrics
02/25/2025
11
GoodRx Holdings Inc Q4 2024 Everything You Need To Know Ahead Of Earnings
02/26/2025
12
GoodRx Misses Q4 Revenue Estimates
02/27/2025
13
Q4 2024 GoodRx Holdings Inc Earnings Call Transcript
02/28/2025
14
Acquisition by Wendy Barnes of 409416 shares of Goodrx Holdings subject to Rule 16b-3
03/03/2025
15
Balanced Outlook on GoodRx Holdings Growth Potential Amidst Cautious Market Expectations - TipRanks
03/04/2025
16
Acquisition by Romin Nabiey of 76866 shares of Goodrx Holdings subject to Rule 16b-3
03/05/2025
17
Disposition of 2233 shares by Romin Nabiey of Goodrx Holdings subject to Rule 16b-3
03/07/2025
18
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
03/10/2025

About Goodrx Holdings Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Goodrx or other stocks. Alpha measures the amount that position in Goodrx Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.06740.0599
Price To Sales Ratio2.262.15

Goodrx Holdings Upcoming Company Events

As portrayed in its financial statements, the presentation of Goodrx Holdings' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Goodrx Holdings' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Goodrx Holdings' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Goodrx Holdings. Please utilize our Beneish M Score to check the likelihood of Goodrx Holdings' management manipulating its earnings.
27th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Goodrx Holdings

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Goodrx Stock Analysis

When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.